Previous studies have confirmed that levels of tumor-infiltrating CD8+ T leukocytes are associated with better prognosis for both overall survival and disease-free survival in HCC patients, but most are inhibited by receptor-ligand interactions [172]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.